Cures Act Encourages Breakthrough Devices, Exempts Medical Software

The GMP Letter
Manufacturing-related provisions in the recently enacted 21st Century Cures Act establish a program for “breakthough” devices, exempt some categories of medical software from regulation as a medical device, and require the FDA to publish a list of reusable device types that must include usage instructions and cleaning data.

To View This Article:


Subscribe To The GMP Letter